BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11913410)

  • 1. Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.
    Lee CM; Kumar RK; Lubowski DZ; Burcher E
    Dig Dis Sci; 2002 Mar; 47(3):495-502. PubMed ID: 11913410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease.
    Kimura M; Masuda T; Hiwatashi N; Toyota T; Nagura H
    Pathol Int; 1994 Aug; 44(8):624-34. PubMed ID: 7524953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurochemical changes in the innervation of human colonic mesenteric and submucosal blood vessels in ulcerative colitis and Crohn's disease.
    de Fontgalland D; Brookes SJ; Gibbins I; Sia TC; Wattchow DA
    Neurogastroenterol Motil; 2014 May; 26(5):731-44. PubMed ID: 24597665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
    Koch TR; Carney JA; Go VL
    Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease.
    Kubota Y; Petras RE; Ottaway CA; Tubbs RR; Farmer RG; Fiocchi C
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1242-51. PubMed ID: 1551531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct morphological evidence of neuroimmunomodulation in colonic mucosa of patients with Crohn's disease.
    Fehér E; Kovács A; Gallatz K; Fehér J
    Neuroimmunomodulation; 1997; 4(5-6):250-7. PubMed ID: 9650818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
    Koch TR; Michener SR; Carney JA; Go VL
    Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.
    Bishop AE; Polak JM; Bryant MG; Bloom SR; Hamilton S
    Gastroenterology; 1980 Nov; 79(5 Pt 1):853-60. PubMed ID: 7419008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the number of neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis].
    Kamińska B; Landowski P; Gonkowski S; Majewski M; Renke J; Korzon M
    Med Wieku Rozwoj; 2006; 10(2):483-91. PubMed ID: 16825719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis.
    Vento P; Kiviluoto T; Keränen U; Järvinen HJ; Kivilaakso E; Soinila S
    J Histochem Cytochem; 2001 Jun; 49(6):749-58. PubMed ID: 11373321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
    Mazumdar S; Das KM
    Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered inhibitory innervation of circular smooth muscle in Crohn's colitis. Association with decreased vasoactive intestinal polypeptide levels.
    Koch TR; Carney JA; Go VL; Szurszewski JH
    Gastroenterology; 1990 Jun; 98(6):1437-44. PubMed ID: 2338187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.
    Camacho FI; Muñoz C; Sánchez-Verde L; Sáez AI; Alcántara M; Rodríguez R
    Histopathology; 1999 Aug; 35(2):144-9. PubMed ID: 10460659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P containing nerve fibers in ulcerative colitis.
    Watanabe T; Kubota Y; Muto T
    Int J Colorectal Dis; 1998; 13(2):61-7. PubMed ID: 9638489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation.
    Straub RH; Grum F; Strauch U; Capellino S; Bataille F; Bleich A; Falk W; Schölmerich J; Obermeier F
    Gut; 2008 Jul; 57(7):911-21. PubMed ID: 18308830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.